TLR2 and COVID-19: In summary, hyperinflammation driven by TLR2/4 activation in both the CNS and the periphery, resulting from its interaction with the S protein, can trigger neurological symptoms and exacerbate myocarditis and multiple organ damage in COVID-19 patients.